Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Accumulated Expenses: 2015-2025

Historic Other Accumulated Expenses for CorMedix (CRMD) over the last 10 years, with Sep 2025 value amounting to $278,684.

  • CorMedix's Other Accumulated Expenses rose 45.15% to $278,684 in Q3 2025 from the same period last year, while for Sep 2025 it was $278,684, marking a year-over-year increase of 45.15%. This contributed to the annual value of $122,357 for FY2024, which is N/A change from last year.
  • Latest data reveals that CorMedix reported Other Accumulated Expenses of $278,684 as of Q3 2025, which was up 104.47% from $136,298 recorded in Q2 2025.
  • CorMedix's Other Accumulated Expenses' 5-year high stood at $436,290 during Q2 2024, with a 5-year trough of $54,763 in Q3 2023.
  • Its 3-year average for Other Accumulated Expenses is $170,112, with a median of $129,328 in 2024.
  • In the last 5 years, CorMedix's Other Accumulated Expenses skyrocketed by 309.25% in 2024 and then plummeted by 68.76% in 2025.
  • CorMedix's Other Accumulated Expenses (Quarterly) stood at $94,736 in 2021, then tumbled by 31.96% to $64,456 in 2022, then crashed by 34.37% to $54,763 in 2023, then spiked by 250.59% to $122,357 in 2024, then surged by 45.15% to $278,684 in 2025.
  • Its Other Accumulated Expenses stands at $278,684 for Q3 2025, versus $136,298 for Q2 2025 and $87,423 for Q1 2025.